244 related articles for article (PubMed ID: 17877961)
1. [Biphosphonates in breast cancer--based on a Cochrane meta-analysis].
Junker N; Nielsen DL; Kamby C
Ugeskr Laeger; 2007 Sep; 169(37):3108-11. PubMed ID: 17877961
[No Abstract] [Full Text] [Related]
2. [Biphosphonates and prostatic cancer. A survey of a Cochrane review].
Jønler M; Borre M
Ugeskr Laeger; 2007 Nov; 169(47):4058-61. PubMed ID: 18078660
[No Abstract] [Full Text] [Related]
3. Pharmacotherapy of bone metastases in breast cancer patients.
Petrut B; Simmons C; Broom R; Trinkaus M; Clemons M
Expert Opin Pharmacother; 2008 Apr; 9(6):937-45. PubMed ID: 18377337
[TBL] [Abstract][Full Text] [Related]
4. Emerging role for bisphosphonates in cancer management.
Chlebowski RT
Breast Dis; 2011; 33(2):55-7. PubMed ID: 22142659
[No Abstract] [Full Text] [Related]
5. [Effects of zoledronic acid in the treatment of breast cancer].
Chen J; Liu ZY; Zhao LJ
Zhonghua Zhong Liu Za Zhi; 2011 Apr; 33(4):318-9. PubMed ID: 21575510
[No Abstract] [Full Text] [Related]
6. Efficacy of clodronate, pamidronate, and zoledronate in reducing morbidity and mortality in cancer patients with bone metastasis: a meta-analysis of randomized clinical trials.
Machado M; Cruz LS; Tannus G; Fonseca M
Clin Ther; 2009 May; 31(5):962-79. PubMed ID: 19539097
[TBL] [Abstract][Full Text] [Related]
7. Bisphosphonates for breast cancer: questions answered, questions remaining.
Layman R; Olson K; Van Poznak C
Hematol Oncol Clin North Am; 2007 Apr; 21(2):341-67. PubMed ID: 17512453
[TBL] [Abstract][Full Text] [Related]
8. [The effect of bisphosphonates on pain relief in patients with bone metastases: A status article based on the Cochrane analysis: "Bisphosphonates for the relief of pain secondary to bone metastasis"].
Ejlertsen B; Kristensen B
Ugeskr Laeger; 2003 May; 165(20):2089-91. PubMed ID: 12812098
[No Abstract] [Full Text] [Related]
9. Bone targeted therapy in breast cancer: present and future.
Huober J; Thürlimann B
Crit Rev Oncol Hematol; 2010 Apr; 74 Suppl 1():S7-10. PubMed ID: 20427030
[No Abstract] [Full Text] [Related]
10. Bisphosphonates as adjuvant therapy.
Shapiro CL
Clin Adv Hematol Oncol; 2009 May; 7(5):319-20. PubMed ID: 19521319
[No Abstract] [Full Text] [Related]
11. New results from the use of bisphosphonates in cancer patients.
Coleman R; Gnant M
Curr Opin Support Palliat Care; 2009 Sep; 3(3):213-8. PubMed ID: 19561507
[TBL] [Abstract][Full Text] [Related]
12. Sowing the soil for cure? Results of the ABCSG-12 trial open a new chapter in the evolving adjuvant bisphosphonate story in early breast cancer.
Bedard PL; Body JJ; Piccart-Gebhart MJ
J Clin Oncol; 2009 Sep; 27(25):4043-6. PubMed ID: 19652062
[No Abstract] [Full Text] [Related]
13. Bisphosphonates--role in cancer therapies.
Mehrotra B
J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):19-26. PubMed ID: 19371811
[No Abstract] [Full Text] [Related]
14. Bisphosphonates in adjuvant setting for breast cancer: a review of the meta-analysis of bisphosphonates' effects on breast cancer recurrence presented in December 2013 at San Antonio Breast Conference.
Costa L
Curr Opin Support Palliat Care; 2014 Dec; 8(4):414-9. PubMed ID: 25319273
[TBL] [Abstract][Full Text] [Related]
15. Bisphosphonates in adjuvant treatment of early breast cancer.
; Harbeck N; von Minckwitz G; Thürlimann B
Crit Rev Oncol Hematol; 2010 Apr; 74 Suppl 1():S1. PubMed ID: 20427026
[No Abstract] [Full Text] [Related]
16. Bisphosphonates for care and cure.
Body JJ
Eur J Cancer; 2009 Sep; 45 Suppl 1():396-7. PubMed ID: 19775644
[No Abstract] [Full Text] [Related]
17. Bisphosphonates in the adjuvant treatment of early breast cancer: conclusion.
Eiermann W
Crit Rev Oncol Hematol; 2010 Apr; 74 Suppl 1():S16-7. PubMed ID: 20427028
[No Abstract] [Full Text] [Related]
18. Clinical efficacy and safety of zoledronic acid in prostate and breast cancer.
Doggrell SA
Expert Rev Anticancer Ther; 2009 Sep; 9(9):1211-8. PubMed ID: 19761424
[TBL] [Abstract][Full Text] [Related]
19. Differential effect of doxorubicin and zoledronic acid on intraosseous versus extraosseous breast tumor growth in vivo.
Ottewell PD; Deux B; Mönkkönen H; Cross S; Coleman RE; Clezardin P; Holen I
Clin Cancer Res; 2008 Jul; 14(14):4658-66. PubMed ID: 18628481
[TBL] [Abstract][Full Text] [Related]
20. Routine adjuvant use of bisphosphonates in breast cancer arguments in favour and against.
Diel I; Aebi S
Crit Rev Oncol Hematol; 2010 Apr; 74 Suppl 1():S11-5. PubMed ID: 20427027
[No Abstract] [Full Text] [Related]
[Next] [New Search]
